Little is known about the ocular and cerebral blood flow during exposure to increasingly hypoxic conditions at high altitudes. There is evidence that an increase in cerebral blood flow resulting from altered autoregulation constitutes a risk factor for acute mountain sickness (AMS) and high-altitude cerebral edema (HACE) by leading to capillary overperfusion and vasogenic cerebral edema. The retina represents the only part of the central nervous system where capillary blood flow is visible and can be measured by noninvasive means. In this study we aimed to gain insights into retinal and choroidal autoregulatory properties during hypoxia and to correlate circulatory changes to symptoms of AMS and clinical signs of HACE. This observational study was performed within the scope of a high-altitude medical research expedition to Mount Muztagh Ata (7,546 m). Twenty seven participants underwent general and ophthalmic examinations up to a maximal height of 6,800 m. Examinations included fundus photography and measurements of retinal and choroidal blood flow, as well as measurement of arterial oxygen saturation and hematocrit. The initial increase in retinal blood velocity was followed by a decrease despite further ascent, whereas choroidal flow increase occurred later, at even higher altitudes. The sum of all adaptational mechanisms resulted in a stable oxygen delivery to the retina and the choroid. Parameters reflecting the retinal circulation and optic disc swelling correlated well with the occurrence of AMS-related symptoms. We demonstrate that sojourns at high altitudes trigger distinct behavior of retinal and choroidal blood flow. Increase in retinal but not in choroidal blood flow correlated with the occurrence of AMS-related symptoms.
presented here on ocular blood flow changes at high altitudes pertain to the ophthalmology project within the scope of this research expedition.
Blood flow alterations in both the brain and the eye occur under the influence of prolonged hypoxia (13, 14) . Cerebral blood flow (CBF) at high altitudes has been shown to increase during the first 24 h and to decrease gradually to normal levels within days (10, 38) and then remain stable after acclimatization (25) . Changes in CBF at different altitudes are of interest as a sign of autoregulatory properties. According to one leading hypothesis, an increase in CBF on a capillary level resulting from altered autoregulation at high altitudes constitutes a risk factor for acute mountain sickness (AMS) and highaltitude cerebral edema (HACE) by leading to capillary overperfusion and vasogenic cerebral edema (17, 41) . However, due to the technical difficulties associated with investigations at very high altitudes, examination of CBF has to date only been possible on the level of larger arteries.
There is a close correlation between the regulation of blood supply to the brain and to the retina, due to similar vascular regulatory processes (9, 28) . The direct visualization of the retinal vasculature and the measurement of blood flow in the capillaries of the macular region of the fundus as well as in the subfoveal choriocapillaris are now possible in an outdoor setting. This allows for the assessment of blood flow on a capillary level, downstream from the large cerebral arteries in an observable part of the central nervous system.
In this study, we aimed to determine the effect of long-term hypoxemia on retinal and choroidal blood flow during a slow ascent to very high altitudes. We investigated whether highaltitude changes in retinal/choroidal blood flow correlate with alterations of retinal vessels and optic disc, and how these changes mirror symptoms and signs of high-altitude cerebral illness.
METHODS

Subjects and Course of Expedition
This prospective, multidisciplinary, observational cohort study was performed within the scope of a high-altitude medical research expedition. Exclusion criteria were any type of ocular, cardiac, or respiratory disease, or a history of high-altitude pulmonary edema or high-altitude cerebral edema (HACE) after a rapid ascent (Ͻ3 nights) at altitudes below 3,500 m. Thirty-four healthy mountaineers were initially enrolled. Seven participants were excluded from the study because of ocular disease before the expedition (n ϭ 2) or because of incomplete data collection during the expedition (n ϭ 5). Data of 27 mountaineers (age 26 -62 yr; mean 43 yr; 6 women and 21 men) were processed. The participants were randomly distributed into two groups, with a different ascent profile for each group (Fig. 1) . The study was approved by the Ethical Committee of the University Hospital, Zurich, and adheres to the tenets of the Declaration of Helsinki (1983 Revision). Informed, written consent was obtained from all subjects before the examinations.
The climb for both groups started at 3,750 m, then continued to base camp (BC ϭ 4,497 m), camp 1 (C1 ϭ 5,533 m), camp 2 (C2 ϭ 6,265 m), camp 3 (C3 ϭ 6,865 m), and to the summit (7,546 m), within 20 and 19 days. The average ascent rate was 190 and 200 m/day, respectively (Fig. 1 ). Examinations were performed at BC and on each subsequent day on arrival at each new high camp and at return to base camp (BC2), having reached at least C2 (Fig. 1) .
Measurements
The participants underwent general and ophthalmic baseline examinations 1 mo before the expedition (ZH1) and 4.5 mo after returning from the expedition (ZH2) at the University Hospital of Zurich (490 m). Baseline eye examinations included testing of best-corrected visual acuity (BCVA) with log MAR charts [ETDRS letters (12) ], fundus photography, and fluorescein angiography (Zeiss FF 450 plus camera, Carl Zeiss AG, Oberkochen, Germany), measurement of retinal blood flow by blue-field simulation (BFS-1000, Oculix, Berwyn, PA), choroidal blood flow by laser-Doppler flowmetry (LDF) (Institut de Recherche en Ophtalmologie, Sion, Switzerland), and measurements of intraocular pressure (IOP; Tono-Pen XL; Medtronic-Solan, Jacksonville, FL). At high altitude, all examinations except fluorescein angiography were performed; fundus photographs were acquired using a hand-held digital fundus camera (Genesis-D, Kowa, Tokyo, Japan). At every examination, 12 digital fundus photographs were taken of each eye with a 30-s interval between each photograph.
Retinal vessel diameters. Vessel diameters of the temporal superior branch retinal artery and vein were measured by projecting identical photograph sections with the same magnification onto a screen. The center of the optic disc was used as the point of reference in all images. Measurements were taken by two independent ophthalmologists at a distance of one disc diameter from the center of the optic disc. Corresponding measurements of both examiners were averaged. Since a direct exact measurement of vessel diameters was not possible, arbitrary units (AU) were used. Changes compared with initial values at ZH1 were expressed as changes in percent and used for further calculations.
Evaluation of optic disc swelling. Optic disc photos of each eye on every examined height were randomized and evaluated in a masked fashion by three ophthalmologists. Guidelines for the criteria of papilledema as described by Walsh and Hoyt (42) were followed. The optic disc of each eye was judged to be either "not swollen" ϭ 0, "equivocal" ϭ 1, or "swollen" ϭ 2 (8, 42) .
Perifoveal retinal blood flow measurements. The blue-field simulation (BFS) technique allows the measurement of retinal blood flow parameters in the macular region of the fundus (33) . This method is based on the observation of each subject's own leukocytes flowing in the perifoveal capillaries within a field of view of ϳ20°of arc diameter centered at the fovea during retinal illumination with blue light (wavelength ϭ 430 nm). This observation is quantified using a psychophysical technique (29) resulting in time-averaged velocity [BFS-Vel (mm/s)] of leukocytes. Surrogate parameters for retinal blood flow oxygen transport capacity (rcO2) and retinal blood flow oxygen delivery (rdO 2) were calculated based on the BFS measurements, arterial oxygen saturation (SaO2), and hematocrit (Hct). The oxygen transport capacity of blood is determined by blood flow over time and the number of red blood cells per given volume of blood, which is equal to the Hct. Using BFS-Vel as the determinant of retinal blood flow, oxygen transport capacity was defined as rcO 2 ϭ BFSVel ϫ Hct. Actual oxygen delivery is also dependent on blood flow, Hct, and percentage of oxygenated red blood cells. Thus retinal blood flow oxygen delivery was defined as rdO2 ϭ rcO2 ϫ SaO2 (SaO2 expressed as a fraction of 1.0).
Subfoveal choroidal blood flow measurements. A portable confocal LDF system (15) for subfoveal choroidal blood flow measurements was utilized. LDF permits localized blood flow measurements in the subfoveal choriocapillaris based on the Doppler shift caused by moving red blood cells (32, 34) . The blood flow parameters velocity (LDF-Vel) and volume (LDF-Vol) (all in arbitrary units) were measured simultaneously in five 10-s sequences (30, 35) . Only data with a steady direct current (DC) trace, which is proportional to the total amount of light reaching the detector, were included (36) . The LDF device simultaneously detects the current heart rate by photoplethysmography using a sensor attached to the subject's ear lobe. Analogous to the retinal blood flow parameters, the following formulas were used to calculate the oxygen transport capacity of choroidal blood (ccO 2) and choroidal oxygen delivery (cdO2): ccO2 ϭ LDF-Vel ϫ LDF-Vol and cdO2 ϭ ccO2 ϫ SaO2. Hematocrit was not included in the equation due to the fact that LDF-Vol already corresponds to the volume of red blood cells within the sample blood volume.
Systemic parameters. Diastolic (P A,dia) and systolic (PA,sys) brachial artery blood pressure were measured with a sphygmomanometry device. Mean systemic blood pressure was defined as PA,dia ϩ 1/3 ϫ (PA,sys Ϫ PA,dia). Hct was measured in capillary blood samples using a template to determine the values after centrifugation (Haematokrit 2010, Hettich, Switzerland). Daily pulse oximetry was performed in the evening during quiet rest in a standing position with a finger pulse oximeter (Onyx 9500 SportStat, Nonin Medical, Plymouth, MN). Stable values after at least 3 min were recorded. Cerebral AMS (AMS-c) scores were assessed daily during the expedition utilizing the Environmental Symptom Questionnaire (ESQ III) (24, 37) . The AMS-c score reflects symptoms of altered cerebral function in conjunction with the feeling of being ill. A score of Ն0.7 reliably identifies a person with AMS (24, 37) . Drug intake was assessed by analyzing daily personal diaries. Intake of nonsteroidal anti-inflammatory agents was allowed by protocol, whereas other medication was taken only on recommendation by the independent expedition physician.
Statistical Analysis
Unless stated otherwise, data are expressed as means Ϯ SD. To account for outliers due to the technical properties of the BFS and LDF measurements as well blinking and saccades, data were transformed to z-scores. Values with a z-score Ͼ 2.58 or Ͻ Ϫ2.58 (upper and lower 0.5% of the data distribution) were excluded from further analysis [4 of 324 measurements for BFS-Vel (1.2%), 3 measurements for LDF-Vel (0.9%), and 9 measurements for LDF-Vol (2.7%)]. As appropriate, one-way or two-way repeated-measures ANOVA was utilized for comparison of measurements on different altitudes, followed by Bonferroni post hoc testing. Assumption of sphericity was tested using Mauchly's sphericity test. GreenhouseGeiser correction was applied in case of violation of the sphericity assumption to calculate the correction factor ε for the degrees of freedom of the analysis. Results are reported as the F-ratio (F), which gives the ratio between the variation explained by the model and the variation explained by unsystematic factors; the accordant degrees of freedom, and ε in case of violation of sphericity; and the significance value. Covariance of BFS-Vel and AMS-c was assessed by correlation analysis. Linear regression analysis was applied to investigate the effect of SaO2 on blood flow parameters. Univariate logistic regression was used to assess the influence of arterial oxygen saturation as well as retinal and choroidal blood flow parameters on occurrence of AMS, as appropriate. Multiple logistic regression, followed by colinearity testing, was used to analyze relations between the different predictors, SaO2 and blood flow parameters. Partial correlation coefficients were expressed as ␤, and the coefficient of determination was expressed as R 2 . A two-sided ␣-error (P value) of Ͻ0.05 was considered statistically significant. Statistical analysis was performed with the software Statistica 6 (StatSoft, Tulsa, OK) and SPSS 13.0 (SPSS, Chicago, IL).
RESULTS
Systemic Changes
An overview of changes in the systemic parameters (blood pressure, Hct, SaO 2 , and AMS-c) is presented in Table 1 . Two climbers were treated for severe headaches with 250 mg acetazolamide, 8 mg of dexamethasone, and 20 mg of nifedipine on the second to last day of the observation period, as they did not respond to ibuprofen. They did not show ataxia or any changes in mental status and recovered after descent to a lower altitude. Two climbers had early HACE at the end of the observation period and but were able to descend to a lower altitude (base camp) immediately where their symptoms improved significantly so that no steroid treatment was necessary. One of these two climbers concurrently took 250 mg acetazolamide on the last day of the observation period. Intake of drugs took place more than 12 h before examination.
Acclimatization occurred over the course of the expedition as evidenced by a SaO 2 at return to base camp that exceeded values first measured.
Eye-Related Changes
Retinal vessel diameter and blood flow. Both arterial and venous calibers increased significantly at high altitudes [F(6,84) ϭ 69.4, P Ͻ 0.0001 for arterial vessels; F(6,84) ϭ 91.78, P Ͻ 0.0001 for venous vessels] (Fig. 2) , the increase of arteries being greater than that of veins (P ϭ 0.004). The most marked changes were noted at BC1 (arterial and venous change compared with ZH1: P Ͻ 0.0001) and at C1 (alteration compared with BC1: P ϭ 0.03 for arterial vessels and P Ͻ 0.0001 for venous vessels). Above C1, arterial and venous diameters stabilized and enlarged only insignificantly up to C3. On descent arterial and venous diameters returned to their initial values, and no significant differences were observed between BC1 and BC2, and ZH1 and ZH2.
Oxygen saturation was a significant predictor of vessel diameters (R 2 ϭ 0.548, ␤ ϭ 0.740, P Ͻ 0.0001 for arterial vessels; R 2 ϭ 0.712, ␤ ϭ 0.844, P Ͻ 0.0001 for venous vessels). Decrease of oxygen saturation by 1% was associated with increase of 1.4 Ϯ 0.1%, and of 1.3 Ϯ 0.06% in arterial and venous vessel diameter, respectively.
Arterial and venous vessel diameters were found to correlate weakly with retinal blood flow velocity as measured by BFS (arterial vessel diameter R 2 ϭ 0.142, ␤ ϭ 0.377, P Ͻ 0.0001; venous vessel diameter R 2 ϭ 0.052, ␤ ϭ 0.220, P ϭ 0.008). No significant correlation with systemic mean arterial blood pressure was found.
Changes in retinal blood flow parameters are shown in Fig. 3 and summarized in Table 2 . BFS-Vel differed significantly at different altitudes [F(5,120) ϭ 20.37, P Ͻ 0.0001]. On initial ascent, central macular blood flow velocity increased and peaked at medium altitudes (6,265 m) and then decreased on continuing ascent. Significant changes were observed between baseline levels and BC1 (P Ͻ 0.0001), whereas a trend for decrease in BFS-Vel was measured between C1 and C2. The values for rcO 2 Values are means Ϯ SD; n ϭ no. of examined subjects. ZH1, baseline examinations at University Hospital of Zurich 1 mo before expedition; BC, initial base camp; C1, C2, and C3, camps 1, 2, and 3; BC2, return to base camp; ZH2, examinations at University Hospital of Zurich 4.5 mo after returning from expedition; SaO2, arterial oxygen saturation; AMS-c score, cerebral acute mountain sickness score ͓Environmental Symptom Questionnaire (ESQ III)͔; MAP, mean systemic blood pressure; Hct, hematocrit; ns, not significant. (Fig. 4) . Mean changes of choroidal blood flow parameters compared with ZH1 (percentage Ϯ SD) are shown in Table 3 . Post hoc analysis did not reveal significant increases in both parameters up to C1 compared with ZH1. A statistically significant increase occurred in C2 (P Ͻ 0.0001 for LDF-Vel; P ϭ 0.003 for LDF-Vol) and was sustained on return to lower altitudes (BC2) (P Ͻ 0.0001 for LDF-Vel; P ϭ 0.004 for LDF-Vol). Reexamination of all subjects 4.5 mo after the expedition (ZH2) showed no significant difference from ZH1 for LDF-Vol, but significantly increased choroidal blood flow velocities (LDF-Vel) (P ϭ 0.003) were apparent. Choroidal oxygen capacity (ccO 2 ) changed at different altitudes [F(55.83,2.14) ϭ 17.74, ε ϭ 0.43, P Ͻ 0.0001], significant changes occurring at C2 and BC2 (both altitudes P Ͻ 0.0001 compared with ZH1). No significant changes in choroidal oxygen delivery (cdO 2 ) were found at different altitudes [F(15.41,2.20) ϭ 2.59, ε ϭ 0.44, P ϭ 0.10] (Fig. 5) . Arterial oxygen saturation was a weak but significant predictor for LDF-Vel (R 2 ϭ 0.1, ␤ ϭ Ϫ0.311, P Ͻ 0.0001) and ccO 2 (R 2 ϭ 0.06, ␤ ϭ Ϫ0.245, P ϭ 0.003) but not for LDF-Vol. Systemic blood pressure did not correlate with choroidal blood flow parameters.
Correlation of retinal and choroidal blood flow parameters and occurrence of AMS. Significant covariance was revealed between BFS-Vel and AMS-c scores by correlation analysis (R 2 ϭ 0.083, P ϭ 0.0004) (Fig. 6 ). Multiple logistic regression revealed arterial retinal vessel diameter [odds ratio (OR) 1.03, 95% confidence interval (CI) 1.006 -1.066, P ϭ 0.017], venous retinal vessel diameter (OR 1.042, 95% CI 1.001-1.084, P ϭ 0.046), and BFS-Vel (OR 12.41, 95% CI of OR 1.4 -106.6, P ϭ 0.022) to be correlated with the development of AMS as defined by an AMS-c score of Ն0.7. In subjects exhibiting optic disc swelling (59% of all mountaineers), the correlation between BFS-Vel and occurrence of AMS was stronger (OR ϭ 14.51, 95% CI 2.08 -101.41; P ϭ 0.007) than in subjects without optic disc swelling (OR ϭ 5.54, 95% CI 1.44 -21.32; P ϭ 0.013). None of the analyzed determinants of choroidal blood flow (LDF-Vel, LDF-Vol, rcO 2 , and rdO 2 ) was associated with the development of AMS. Low arterial oxygen saturation also correlated with increased incidence of AMS symptoms (OR ϭ 0.911, 95% CI 0.852-0.975, P ϭ 0.007). In multiple logistic regression models, including SaO 2 and vessel diameters, or SaO 2 and BFS-Vel as predictors of development of AMS symptoms, all parameters lost significance for the development of AMS. Colinearity diagnostics revealed significant colinearity between SaO 2 and BFS-Vel on the one hand, and SaO 2 and vessel diameters on the other hand, thus explaining this finding.
Best-corrected visual acuity and fluorescein angiography. No significant decrease in BCVA was noted during the course of the expedition. No changes in fluorescein angiography were found after the expedition compared with initial examinations.
DISCUSSION
The present study demonstrates significant changes in the circulation parameters of the eye with increasing altitude. Both retinal and choroidal blood velocity increased during prolonged hypoxic conditions. The initial increase in macular retinal blood velocity was followed by a decrease at higher altitudes despite further ascent, whereas choroidal flow increase occurred later, at even higher altitudes. Moreover, parameters reflecting the retinal circulation, that is, macular retinal blood velocity and increase in vessel caliber, correlated with the development of AMS symptoms, suggesting a pathophysiological link, whereas such associations were not detected for choroidal circulation parameters. Interestingly, despite these marked and significant temporary changes, the eye's visual acuity was not affected, and no temporary or persistent damage could be detected. The retina is one of the most metabolically active tissues (4) in the human body; it features a distinctly regulated dual circulation by retinal and choroidal vessels. The outer retina, comprised of photoreceptors with a very high oxygen consumption rate, mainly relies on choroidal perfusion, whereas the inner retina, encompassing bipolar, amacrine, horizontal, and ganglion cells, mainly depends on retinal perfusion (7). The retinal blood flow is tightly regulated by tissue oxygen tension (PO 2 ) (2, 11, 27); thus a drop in arterial oxygen partial pressure (Pa O 2 ) induces an immediate increase in retinal blood flow. In contrary, the choroidal blood flow shows less apparent oxygen regulation (7); choroidal oxygen delivery is characterized by high blood flow rate and low oxygen extraction and is less sensitive to lower Pa O 2 (3, 22) .
Short-term hypoxia has been shown to induce dilation of retinal vessels (20) . Long-term hypobaric hypoxia studies by Frayser et al. (13), who examined mountaineers at a maximum altitude of 5,300 m, showed a marked increase in retinal blood flow. They reported an increase of 89% in retinal blood flow within 2 h of arrival at altitude, a 128% increase over control flow after 5 days, and an increase of 174% after 7 wk (14) .
Our study subjects were exposed to chronic and severe hypobaric hypoxia, and their retinal arterial and venous vessel caliber increased during ascent to higher altitudes and quickly decreased on descent. This finding supports the results of the animal study by Ahmed et al. (1) , in which the maximum vascular dilation was found to occur at Pa O 2 values Ͻ 40 mmHg. The vessel calibers stabilized above 5,500 m and enlarged only insignificantly at 6,800 m. We suggest the causes to be mechanical and anatomic restrictions of these retinal vessels.
Retinal blood flow velocity showed a steady decline during the climb above 5,500 m after an initial increase (Fig. 3) . As blood flow velocity is dependent on vessel diameter, perfusion pressure, and blood viscosity, the significant increase in hematocrit with time spent at high altitudes may have contributed to this deceleration. The sum of all adaptational mechanisms was shown to result in a stable retinal oxygen delivery (rdO 2 ) throughout the high-altitude expedition. The quick adaptation of the retinal circulation to hypoxemia with increasing altitude may be due to the preexisting maximum oxygen extraction (40) and due to the known sensitivity of the retinal circulation to altered blood oxygen concentration (16) .
In contrast to the retinal perfusion, choroidal blood flow velocity and oxygen-carrying capacity did not increase after ascent to medium heights of 4,497 m (BC1) and 5,533 m (C1) but did increase after ascent to 6,265 m (C2) and was sustained after descent to 4,497 m (BC2). Calculated oxygen delivery showed a similar trend to increase, which was not, however, statistically significant. As changes in choroidal oxygen requirements are improbable, we assume that other factors may have been responsible for the delay of increase in oxygencarrying capacity and oxygen delivery. Oxygen extraction is very low in the choroid, resulting in a high reserve of oxygen transport capacity (2, 43) . Given this low oxygen extraction rate in nonhypoxic conditions, we hypothesize that the initial drop in oxygen delivery can be compensated by an increase in oxygen extraction. Choroidal blood flow increases only after a substantial drop in venous saturation, which results in reduced oxygen diffusion from the vessels into the tissue to avoid a further increase of the arteriovenous oxygen difference. Additionally, retinal and choroidal blood flow is influenced by the arterial carbon dioxide tension (Pa CO 2 ) (19, 32, 39) . This effect is mediated by pH changes in the extracellular tissue surrounding the blood vessels, which leads to arterial vasoconstriction in the retinal as well as the choroidal circulation. Pronounced hypocapnia occurs at high altitude due to a hypoxia-induced increase in alveolar ventilation. In the course of the acclimatization process, renal compensation of respiratory alkalosis takes place, thus reducing pH and hypocapnic vasoconstriction. The vasoconstrictory effect of hypocapnia at the beginning of the acclimatization period is likely to be more pronounced in the choroidal circulation. The oxygen transport capacity is not flow limited in the choroidal circulation, compared with the retinal circulation, which depends on an increased flow to provide sufficient oxygen for the surrounding tissue. Therefore, while the vasoconstrictory effect of hypocapnia per se might be the same on retinal and choroidal blood flow, the more severe hypoxia in the retinal circulation might induce a more pronounced vasodilatory response in the retinal circulation and thus offset the Pa CO 2 response. We did not measure arterial blood gases and choroidal venous blood PO 2 on site, but we hypothesize that hypocapnia may have contributed to the observed differences between choroidal and retinal blood flow in our subjects. Available data on the influence of hypoxia and hypoxic hypocapnia on human choroidal blood flow are very scarce, and we are not aware of studies assessing the impact of prolonged and marked hypoxic conditions as experienced by our subjects. Kergoat et al. (22) reported the effects of transient mild systemic hypoxia (breathing of 12% oxygen) on choroidal blood flow in healthy volunteers. The described experimental condition is comparable to the severity of hypoxia our climbers were subjected to while ascending to altitudes up to 5,500 m during the initial acclimatization period. The above authors did not find a change in choroidal blood flow in their subjects, which is consistent with the results in our climbers who showed stable choroidal blood flow measurements up to C1 with an increase at even higher altitudes.
There is a close anatomic correlation between the vascular blood supply to the brain and the retina, due to similar vascular regulatory processes (9, 28) . Direct visualization of the retina, which is a contiguous part of the central nervous system, and its capillary circulation allows for potential new insights into the pathophysiology of AMS and HACE. A leading hypothesis relates AMS to early stages of brain edema, which might progress to overt HACE in susceptible mountaineers (17) . Whether an increase in CBF plays a pathogenic role in AMS continues to be a matter of debate. Diverging results of CBF measurements in hypoxic conditions have been reported in different studies, showing normal or increased blood flow velocities and an inconsistent relationship to AMS-related symptoms (5, 6, 26, 31) . However, in the more recent literature, the concept of increased CBF, as measured by extracranial Doppler, to be a major determinant of the occurrence of AMS has been more and more abandoned. Instead, altered autoregulation of CBF, allowing for an overperfusion of cerebral capillaries, which then leads to consecutive vasogenic cerebral edema, has been suggested to be the main cause of AMS symptoms (18, 21, 23, 41) .
In our study subjects, the development of AMS symptoms correlated with a higher increase in retinal capillary blood flow and with optic disc swelling, as reported earlier (8), but not with changes in choroidal blood flow. It is possible that an increased retinal blood flow may contribute to the development of optic disc swelling (8) . Similarly, an increased blood flow in the cerebral capillary bed may lead to vasogenic brain edema in persons with severe AMS or HACE.
Whereas transcranial Doppler measures global CBF in large arteries, Doppler flowmetry allows for the measurement of blood flow in the capillaries of the central nervous system, exactly where an overperfusion and consecutive cerebral edema would be expected to take place. Thus results reported in studies using duplex sonography lacking correlation between an increase in CBF and AMS-related symptoms do not necessarily conflict with our findings, which show a correlation between capillary blood flow and AMS scores.
Despite the logistical and technical difficulties associated with medical research in such a challenging environment, we were able to collect novel data in a large group of subjects in very high altitudes (6,865 m). We could demonstrate that sojourns at high altitudes trigger distinct behavior of retinal and choroidal blood flow. These data support the hypothesis that an increase in cerebral blood flow is an important contributing factor in the development of AMS, which may result in cerebral edema, leading to the potentially lethal HACE in susceptible individuals. 
